Dongju Zhao

Dongju Zhao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in ACS Nano
Verified
Journal Article
Closed access
YLYining Liu
Yining Liu
DZDongju Zhao
Dongju Zhao
FYFan Yang
Fan Yang
CYCaihua Ye
Caihua Ye
ZCZiyao Chen
Ziyao Chen
JCJin Chang
Jin Chang

11 August 2023 in ACS Nano
Verified
Journal Article
Closed access
FYFan Yang
Fan Yang
DZDongju Zhao
Dongju Zhao
MCMeng Cheng
Meng Cheng
YLYining Liu
Yining Liu
ZCZiyao Chen
Ziyao Chen
YDYan Dou
Yan Dou

25 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YDYan Dou
Yan Dou
DZDongju Zhao
Dongju Zhao
Natural molecules with favorable safety profile and broad pharmacological activities have shown great promise in the treatment of various neurodegenerative diseases (NDDs). Current studies applying natural molecules against NDDs mainly focus on well-recognized conventional pathogenesis, such as toxic protein aggregation, oxidative stress, and neuroinflammation. However, accumulating evidence reveals that some underlying pathogenic mechanisms are involved earlier and more deeply in the occurrence and development of NDDs, such as ferroptosis, energy metabolism disorders, autophagy-lysosomal dysfunction, endoplasmic reticulum stress, and gut dysbiosis. Therefore, determining whether natural molecules can play therapeutic roles in these emerging pathogenic mechanisms will help clarify the actual targets of natural molecules and their future clinical translation. Furthermore, how to overcome the inability of most poorly water-soluble natural molecules to cross the blood–brain barrier is also critical for effective NDD treatment. This review summarizes emerging pathogenic mechanisms targeted by natural molecules for NDD treatment, proposes nanocarrier-based drug delivery and intranasal administration to enhance the intracerebral bioavailability of natural molecules, and summarizes the current state of clinical research on natural product-based therapeutics.

5 November 2024 in ACS Nano
Verified
Journal Article
Closed access
YLYining Liu
Yining Liu
DZDongju Zhao
Dongju Zhao
FYFan Yang
Fan Yang
CYCaihua Ye
Caihua Ye
ZCZiyao Chen
Ziyao Chen
JCJin Chang
Jin Chang

15 June 2026 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
DZDongju Zhao
Dongju Zhao
KHKun Hou
Kun Hou
HSHuixian Sun
Huixian Sun
ZLZhenxing Liu
Zhenxing Liu
YLYuyin Li
Yuyin Li
ADAipo Diao
Aipo Diao